Compound Detail
CHEMBL5085192
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Cn1cc(Nc2nccc(-c3ccc4c(c3)CN(CC(F)(F)F)CC[C@H]4NC(=O)c3cn(C(C)(C)C)nn3)n2)cn1
Basic Information
| ChEMBL ID | CHEMBL5085192 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ARSHLFAGIBAPNW-JOCHJYFZSA-N |
2
Targets
2
Activities
1
Assay Types
1
PK Parameters
4
Publications
0
Known Names
Molecular Properties
568.6
MW (Da)
4.21
ALogP
10
HBA
2
HBD
118.7
PSA (Ų)
0.36
QED
1
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 7.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Early activation antigen CD69 CHEMBL3308911 | IC50 | 7.0 | 7.0 | 100.0 | 1 |
| Tyrosine-protein kinase BTK CHEMBL5251 | IC50 | 6.3 | 6.3 | 505.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| Fu | 0.02 | - | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Early activation antigen CD69 | IC50 | = | 100.0 | nM | 7.0 | Inhibition of CD69 in human whole blood preincubated for 30 mins followed by ant... | 34734694 |
| Tyrosine-protein kinase BTK | IC50 | = | 505.0 | nM | 6.3 | In Vitro BTK Kinase Assay: The purpose of the BTK in vitro assay is to determine... | - |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 34734694 | 10.1021/acs.jmedchem.1c00926 | No relevant target | 4 |
| 34734694 | 10.1021/acs.jmedchem.1c00926 | ADMET | 3 |
| 34734694 | 10.1021/acs.jmedchem.1c00926 | Tyrosine-protein kinase BTK | 1 |
| 34734694 | 10.1021/acs.jmedchem.1c00926 | Early activation antigen CD69 | 1 |
Data from ChEMBL 36 via Core Engine